Federal Register / Vol. 75, No. 235 / Wednesday, December 8, 2010 / Notices 76477 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: December 2, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–30810 Filed 12–7–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of General Medical 

Sciences; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

General Medical Sciences Special Emphasis 

Panel MBRS Score Grant Applications 

Review. 

Date: December 21, 2010. 

Time: 1 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Natcher Building, 45 Center Drive, Room 

3AN18, Bethesda, MD 20892. (Telephone 

Conference Call). 

Contact: Lisa Dunbar, PhD, Scientific 

Review Officer, Office of Scientific Review, 

National Institute of General Medical 

Sciences, National Institutes of Health, 45 

Center Drive, Room 3AN12, Bethesda, MD 

20892. 301–594–2849. dunbarl@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.375, Minority Biomedical 

Research Support; 93.821, Cell Biology and 

Biophysics Research; 93.859, Pharmacology, 

Physiology, and Biological Chemistry 

Research; 93.862, Genetics and 

Developmental Biology Research; 93.88, 

Minority Access to Research Careers; 93.96, 

Special Minority Initiatives, National 

Institutes of Health, HHS) 

Dated: December 2, 2010. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–30825 Filed 12–7–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Amended 

Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the Center for Scientific 

Review Special Emphasis Panel, 

December 28, 2010, 8 a.m. to December 

29, 2010, 5 p.m., National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, 

MD 20892 which was published in the 

Federal Register on November 29, 2010, 

75 FR 73114–73115. 

The meeting will be held January 6, 

2011 to January 7, 2011. The meeting 

time and location remain the same. The 

meeting is closed to the public. 

Dated: December 2, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–30823 Filed 12–7–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflicts: CIMG and GMPB. 

Date: December 21, 2010. 

Time: 12 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Patricia Greenwel, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2178, 

MSC 7818, Bethesda, MD 20892, 301–435– 

1169. greenwep@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: December 2, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–30821 Filed 12–7–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Auditory and Vestibular 

Neuroscience. 

Date: December 13, 2010. 

Time: 1 p.m. to 2:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call) 

Contact Person: John Bishop, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5182, 

MSC 7844, Bethesda, MD 20892, (301) 408– 

9664, bishopj@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 


jlentini on DSKJ8SOYB1PROD with NOTICES
76478 Federal Register / Vol. 75, No. 235 / Wednesday, December 8, 2010 / Notices 

Dated: December 2, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–30818 Filed 12–7–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Heart, Lung, and Blood 

Institute; Amended Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the National Heart, Lung, 

and Blood Institute Special Emphasis 

Panel, December 14, 2010, 8 a.m. to 

December 14, 2010, 2 p.m., Doubletree 

Hotel Bethesda (Formerly Holiday Inn 

Select), 8120 Wisconsin Avenue, 

Bethesda, MD 20814 which was 

published in the Federal Register on 

November 17, 2010, FR2010–28981. 

The meeting location changed from 

Doubletree Hotel Bethesda to Hyatt 

Regency Bethesda, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. The 

meeting is closed to the public. 

Dated: December 2, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–30816 Filed 12–7–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of 

Meetings 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of meetings of the AIDS 

Research Advisory Committee, NIAID. 

The meetings will be open to the 

public, with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

Name of Committee: AIDS Research 

Advisory Committee, NIAID. 

Date: February 7, 2011. 

Time: 1 p.m. to 5:30 p.m. 

Agenda: Reports from the Division Director 

and other staff. 

Place: National Institutes of Health, 

Natcher Building, 45 Center Drive, 

Conference Rooms E1/E2, Bethesda, MD 

20892. 

Contact: Rona L. Siskind, Executive 

Secretary, AIDS Research Advisory 

Committee, Division of AIDS, NIAID/NIH, 

6700B Rockledge Drive, Room 4139, 

Bethesda, MD 20892–7601. 301–435–3732. 

Name of Committee: AIDS Research 

Advisory Committee, NIAID. 

Date: May 23, 2011. 

Time: 1 p.m. to 5 p.m. 

Agenda: Reports from the Division Director 

and other staff. 

Place: National Institutes of Health, 

Natcher Building, 45 Center Drive, 

Conference Rooms E1/E2, Bethesda, MD 

20892. 

Contact: Rona L. Siskind, Executive 

Secretary, AIDS Research Advisory 

Committee, Division of AIDS, NIAID/NIH, 

6700B Rockledge Drive, Room 4139, 

Bethesda, MD 20892–7601. 301–435–3732. 

Name of Committee: AIDS Research 

Advisory Committee, NIAID. 

Date: September 19, 2011. 

Time: 1 p.m. to 5 p.m. 

Agenda: Reports from the Division Director 

and other staff. 

Place: National Institutes of Health, 

Natcher Building, 45 Center Drive, 

Conference Rooms E1/E2, Bethesda, MD 

20892. 

Contact: Rona L. Siskind, Executive 

Secretary, AIDS Research Advisory 

Committee, Division of AIDS, NIAID/NIH, 

6700B Rockledge Drive, Room 4139, 

Bethesda, MD 20892–7601. 301–435–3732. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: December 2, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–30808 Filed 12–7–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Mandatory Guidelines for Federal 

Workplace Drug Testing Programs 

AGENCY: Substance Abuse and Mental 

Health Services Administration, 

Department of Health and Human 

Services. 

ACTION: HHS Approval of Entities That 

Certify Medical Review Officers 

(MROs). 

SUMMARY: The recent revisions to the 

Department of Health and Human 

Services (HHS) Mandatory Guidelines 

for Federal Workplace Drug Testing 

Programs (Mandatory Guidelines) which 

took effect on October 1, 2010 address 

the role and qualifications of Medical 

Review Officers (MROs) and HHS 

approval of entities that certify MROs. 

Subpart M–Medical Review Officer 

(MRO), Section 13.1(b), ‘‘Who may serve 

as an MRO?’’ states as follows: 

‘‘Nationally recognized entities that 

certify MROs or subspecialty boards for 

physicians performing a review of 

Federal employee drug testing results 

that seek approval by the Secretary must 

submit their qualifications and a sample 

examination. Based on an annual 

objective review of the qualifications 

and content of the examination, the 

Secretary shall publish a list in the 

Federal Register of those entities and 

boards that have been approved.’’ 

HHS has completed its review of 

entities that train and certify MROs, in 

accordance with requests submitted by 

such entities to HHS. 

(1) The HHS Secretary approves the 

following MRO certifying entities that 

offer both MRO training and 

certification through examination: 

American Association of Medical 

Review Officers (AAMRO), P.O. Box 

12873, Research Triangle Park, NC 

27709. Phone: (800) 489–1839, Fax: 

(919) 490–1010, E-mail: 

cferrell@aamro.com. Web site: http:// 

www.aamro.com/. 

Medical Review Officer Certification 

Council (MROCC), 836 Arlington 

Heights Road, #327, Elk Grove 

Village, IL 60007. Phone: (847) 631– 

0599, Fax: (847) 483–1282, E-mail: 

mrocc@mrocc.org. Web site: http:// 

www.mrocc.org/. 

(2) The HHS Secretary approves the 

following entities that offer MRO 

training as a prerequisite for MRO 

certification: 

American College of Occupational and 

Environmental Medicine (ACOEM), 

25 Northwest Point Boulevard, Suite 

700, Elk Grove Village, IL 60007– 

1030, Phone: (847) 818–1800, Fax: 

(847) 818–9266, Contact Form: 

http://www.acoem.org/ 

contactacoem.aspx. Web site: http:// 

www.acoem.org/. 

American Society of Addiction 

Medicine (ASAM), 4601 N. Park 

Avenue, Upper Arcade #101, Chevy 


jlentini on DSKJ8SOYB1PROD with NOTICES